WELLS FARGO & COMPANY/MN - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 26 filers reported holding REGULUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$175
-6.4%
128
+0.8%
0.00%
Q2 2023$187
+107.8%
127
+19.8%
0.00%
Q1 2023$90
-28.6%
106
+15.2%
0.00%
Q4 2022$12692
+2.2%
0.00%
Q3 2022$0
-100.0%
90
-87.5%
0.00%
Q2 2022$1,0007180.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 555,555$1,150,0000.31%
Ikarian Capital, LLC 105,341$217,0000.04%
Sarissa Capital Management LP 185,183$383,0000.04%
FEDERATED HERMES, INC. 2,904,826$6,013,0000.02%
Virtu Financial LLC 10,205$21,0000.00%
VICTORY CAPITAL MANAGEMENT INC 221,506$459,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 11,583$24,0000.00%
VANGUARD GROUP INC 372,732$772,0000.00%
UBS Group AG 8,252$17,0000.00%
Community Bank, N.A. 690$1,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders